Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

Market Cap	28.00B +16.8%
Revenue (ttm)	6.01B -25.8%
Net Income	-278.89M
EPS	-0.17
Shares Out	1.67B
PE Ratio	n/a
Forward PE	18.94
Dividend	0.60 (3.60%)
Ex-Dividend Date	Oct 22, 2025

Volume	30,680,569
Average Volume	15,494,647
Open	16.57
Previous Close	16.76
Day's Range	16.57 - 17.25
52-Week Range	13.12 - 21.58
Beta	0.61
RSI	54.69
Earnings Date	Apr 28, 2026

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 11,708
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002603